/cloudfront-us-east-2.images.arcpublishing.com/reuters/ELYBYTG4QZMUJPXRYDKAVNSTAI.jpg "New branded drugs helping Teva Pharm move closer to growth | Reuters")
New branded drugs helping Teva Pharm move closer to growth | Reuters
Teva Seeking FDA OK to Make Generic of Firdapse for LEMS | But Therapy Maker Catalyst Vows to Enforce Its Property Rights | Lambert-Eaton News
FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
Generic EpiPen by Teva Wins FDA Nod After 2 Year Delay | Fierce Pharma
Teva tumbles as sales and earnings underwhelm
Generic drugmakers Teva and Sandoz make major push to biosimilars | Reuters
Alvotech and Teva Announce Acceptance of U.S. Biologics License Application for AVT04, a Proposed Biosimilar to Stelara® (ustekinumab)
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
Teva Doubles Production as Japanese Change Attitude to Generics
Teva changes course in Japan and the US
Teva® Announces the Arrival of its Latest Collection for Fall 2022
Teva Analysts Say Migraine Drug Approval Gives Needed Relief - Bloomberg
Teva recalls seizure drug | Fierce Pharma
Teva subsidiary opens $100m manufacturing facility in Croatia
FDA Rejects Teva's Application For Huntington's Drug - WSJ
US FDA accepts Teva-MedinCell's NDA for drug to treat schizophrenia
FDA News Roundup Teva AstraZeneca Amgen Medicines Company And More
Teva's Adderall Shortage Seen Continuing Into March (TEVA) - Bloomberg
Teva files potential blockbuster migraine drug for FDA approval
Teva Pursues Regulatory Approval in Japan for MS Drug Copaxone
TEVA | Market Realist
Meet The New Teva: 8% Global Generics Share, 300 ANDAs, 1,500 Launches :: Scrip
Teva expects FDA preapproval inspection of troubled Celltrion plant this year | Fierce Pharma
Teva: Definitely Undervalued (NYSE:TEVA) | Seeking Alpha
